WESTFORD, Mass., June 14 /PRNewswire-FirstCall/ -- Cynosure, Inc. , a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it has been selected to join the Russell 3000(R) Index, according to a preliminary list of additions posted Tuesday on www.russell.com. Final index membership is scheduled to take effect on Friday, June 22, 2007 and to remain in place for the ensuing 12 months.
“We are pleased with our pending inclusion in the Russell 3000 Index, which we believe will enhance our visibility among institutional investors,” said President and Chief Executive Officer Michael Davin.
The Russell 3000 Index measures the performance of the 3,000 largest U.S. companies based on total market capitalization, which represents approximately 98% of the investable U.S. equity market. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. Investment managers who oversee these funds purchase shares of member stocks according to that company’s weighting in the particular index. Annual reconstitution of the Russell indexes captures the 3,000 largest U.S. publicly traded stocks as of the end of May, ranking them by total market capitalization to create the Russell 3000. The largest 1,000 companies in the ranking comprise the Russell 1000 while the remaining 2,000 companies become the widely used Russell 2000.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure’s products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991.
For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Contact Scott Solomon Vice President Sharon Merrill Associates, Inc. 617-542-5300 cyno@investorrelations.com
Cynosure, Inc.
CONTACT: Scott Solomon , Vice President of Sharon Merrill Associates,Inc., +1-617-542-5300, cyno@investorrelations.com
Web site: http://www.cynosurelaser.com//
